Piperazine

Piperazine

SCHEMBL28878799

C1CNCCN1.CC(C)(O)S(=O)(=O)O

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
CYP3A4 P08684 1/20 0.39
GABRA1 P14867 1/20 0.39
TSHR P16473 1/20 0.39
GABRG2 P18507 1/20 0.39
NFKB1 P19838 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRA6 Q16445 1/20 0.39
HIF1A Q16665 1/20 0.33
MAPT P10636 1/20 0.33
PDE4A P27815 1/20 0.33
KDR P35968 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL645048 0.82
SCHEMBL10812480 0.78
Sulfuric Acid SCHEMBL10882768 0.78 CA5A (0.46) LMNATSHR
SCHEMBL7637714 0.78
SCHEMBL12982911 0.78
Water SCHEMBL11586450 0.76 CA5A (0.33) TSHR
Piperazine SCHEMBL27330293 0.76 LMNA (0.46) LMNACYP3A4GABRA1TSHRGABRG2
Piperazine SCHEMBL27671947 0.76 LMNA (0.46) LMNACYP3A4GABRA1TSHRGABRG2
Piperazine SCHEMBL11121855 0.76 CYP3A4 (0.46) LMNACYP3A4GABRA1TSHRGABRG2
SCHEMBL2585493 0.76 CYP3A4 (0.46) LMNACYP3A4GABRA1TSHRGABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115279378-A Ophthalmic compositions comprising D2O 西德奈克西斯公司 2022-11-01 CN disclosed